Cargando…

Recommendations for rheumatologists on pharmacological management during the COVID-19 health emergency: Expert group opinion()

Coronavirus 2019 (COVID-19) is an unexpected pandemic that has caused a state of emergency, as well as generating drastic changes in clinical care protocols. Some drugs commonly used in rheumatoid arthritis, systemic lupus erythematosus, and other systemic autoimmune diseases have been described for...

Descripción completa

Detalles Bibliográficos
Autores principales: López, Josué-Guillermo, Camacho-Barbosa, Jhyld-Carolaind, Felipe-Díaz, Oscar-Jair, Rojas-Zuleta, Wilmer-Gerardo, Ballesteros, Jesús-Giovanny, Navarro-Mendoza, Erika-Paola, Giraldo Herrera, Claudia-Lucía, Giraldo-Bustos, Rodrigo, Padilla-Tovar, Lácides, Duque-Zapata, Natalia, Orozco González, Catalina, López-Mora, María-José, Donado, Jorge-Hernando
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Asociación Colombiana de Reumatología. Published by Elsevier España, S.L.U. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8041268/
http://dx.doi.org/10.1016/j.rcreue.2020.05.009
_version_ 1783677908081967104
author López, Josué-Guillermo
Camacho-Barbosa, Jhyld-Carolaind
Felipe-Díaz, Oscar-Jair
Rojas-Zuleta, Wilmer-Gerardo
Ballesteros, Jesús-Giovanny
Navarro-Mendoza, Erika-Paola
Giraldo Herrera, Claudia-Lucía
Giraldo-Bustos, Rodrigo
Padilla-Tovar, Lácides
Duque-Zapata, Natalia
Orozco González, Catalina
López-Mora, María-José
Donado, Jorge-Hernando
author_facet López, Josué-Guillermo
Camacho-Barbosa, Jhyld-Carolaind
Felipe-Díaz, Oscar-Jair
Rojas-Zuleta, Wilmer-Gerardo
Ballesteros, Jesús-Giovanny
Navarro-Mendoza, Erika-Paola
Giraldo Herrera, Claudia-Lucía
Giraldo-Bustos, Rodrigo
Padilla-Tovar, Lácides
Duque-Zapata, Natalia
Orozco González, Catalina
López-Mora, María-José
Donado, Jorge-Hernando
author_sort López, Josué-Guillermo
collection PubMed
description Coronavirus 2019 (COVID-19) is an unexpected pandemic that has caused a state of emergency, as well as generating drastic changes in clinical care protocols. Some drugs commonly used in rheumatoid arthritis, systemic lupus erythematosus, and other systemic autoimmune diseases have been described for its treatment. Therefore, there is an imminent risk of shortages. The aim of this narrative review and expert opinion is to present general recommendations on the clinical and administrative management of outpatients with autoimmune or systemic inflammatory disease, in the context of the COVID-19 pandemic.
format Online
Article
Text
id pubmed-8041268
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Asociación Colombiana de Reumatología. Published by Elsevier España, S.L.U.
record_format MEDLINE/PubMed
spelling pubmed-80412682021-04-13 Recommendations for rheumatologists on pharmacological management during the COVID-19 health emergency: Expert group opinion() López, Josué-Guillermo Camacho-Barbosa, Jhyld-Carolaind Felipe-Díaz, Oscar-Jair Rojas-Zuleta, Wilmer-Gerardo Ballesteros, Jesús-Giovanny Navarro-Mendoza, Erika-Paola Giraldo Herrera, Claudia-Lucía Giraldo-Bustos, Rodrigo Padilla-Tovar, Lácides Duque-Zapata, Natalia Orozco González, Catalina López-Mora, María-José Donado, Jorge-Hernando Revista Colombiana de Reumatología (English Edition) Reflexion Article Coronavirus 2019 (COVID-19) is an unexpected pandemic that has caused a state of emergency, as well as generating drastic changes in clinical care protocols. Some drugs commonly used in rheumatoid arthritis, systemic lupus erythematosus, and other systemic autoimmune diseases have been described for its treatment. Therefore, there is an imminent risk of shortages. The aim of this narrative review and expert opinion is to present general recommendations on the clinical and administrative management of outpatients with autoimmune or systemic inflammatory disease, in the context of the COVID-19 pandemic. Asociación Colombiana de Reumatología. Published by Elsevier España, S.L.U. 2021 2021-04-12 /pmc/articles/PMC8041268/ http://dx.doi.org/10.1016/j.rcreue.2020.05.009 Text en © 2020 Asociación Colombiana de Reumatología. Published by Elsevier España, S.L.U. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Reflexion Article
López, Josué-Guillermo
Camacho-Barbosa, Jhyld-Carolaind
Felipe-Díaz, Oscar-Jair
Rojas-Zuleta, Wilmer-Gerardo
Ballesteros, Jesús-Giovanny
Navarro-Mendoza, Erika-Paola
Giraldo Herrera, Claudia-Lucía
Giraldo-Bustos, Rodrigo
Padilla-Tovar, Lácides
Duque-Zapata, Natalia
Orozco González, Catalina
López-Mora, María-José
Donado, Jorge-Hernando
Recommendations for rheumatologists on pharmacological management during the COVID-19 health emergency: Expert group opinion()
title Recommendations for rheumatologists on pharmacological management during the COVID-19 health emergency: Expert group opinion()
title_full Recommendations for rheumatologists on pharmacological management during the COVID-19 health emergency: Expert group opinion()
title_fullStr Recommendations for rheumatologists on pharmacological management during the COVID-19 health emergency: Expert group opinion()
title_full_unstemmed Recommendations for rheumatologists on pharmacological management during the COVID-19 health emergency: Expert group opinion()
title_short Recommendations for rheumatologists on pharmacological management during the COVID-19 health emergency: Expert group opinion()
title_sort recommendations for rheumatologists on pharmacological management during the covid-19 health emergency: expert group opinion()
topic Reflexion Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8041268/
http://dx.doi.org/10.1016/j.rcreue.2020.05.009
work_keys_str_mv AT lopezjosueguillermo recommendationsforrheumatologistsonpharmacologicalmanagementduringthecovid19healthemergencyexpertgroupopinion
AT camachobarbosajhyldcarolaind recommendationsforrheumatologistsonpharmacologicalmanagementduringthecovid19healthemergencyexpertgroupopinion
AT felipediazoscarjair recommendationsforrheumatologistsonpharmacologicalmanagementduringthecovid19healthemergencyexpertgroupopinion
AT rojaszuletawilmergerardo recommendationsforrheumatologistsonpharmacologicalmanagementduringthecovid19healthemergencyexpertgroupopinion
AT ballesterosjesusgiovanny recommendationsforrheumatologistsonpharmacologicalmanagementduringthecovid19healthemergencyexpertgroupopinion
AT navarromendozaerikapaola recommendationsforrheumatologistsonpharmacologicalmanagementduringthecovid19healthemergencyexpertgroupopinion
AT giraldoherreraclaudialucia recommendationsforrheumatologistsonpharmacologicalmanagementduringthecovid19healthemergencyexpertgroupopinion
AT giraldobustosrodrigo recommendationsforrheumatologistsonpharmacologicalmanagementduringthecovid19healthemergencyexpertgroupopinion
AT padillatovarlacides recommendationsforrheumatologistsonpharmacologicalmanagementduringthecovid19healthemergencyexpertgroupopinion
AT duquezapatanatalia recommendationsforrheumatologistsonpharmacologicalmanagementduringthecovid19healthemergencyexpertgroupopinion
AT orozcogonzalezcatalina recommendationsforrheumatologistsonpharmacologicalmanagementduringthecovid19healthemergencyexpertgroupopinion
AT lopezmoramariajose recommendationsforrheumatologistsonpharmacologicalmanagementduringthecovid19healthemergencyexpertgroupopinion
AT donadojorgehernando recommendationsforrheumatologistsonpharmacologicalmanagementduringthecovid19healthemergencyexpertgroupopinion